I. Peretz

发表

Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study

D. Goldstein, H. Goldvaser, Assaf Moore, 2020, Sarcoma.

Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer

A. Allen, O. Jacobi, Y. Landman, 2021, Oncoimmunology.

Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC

T. Siegal, J. Bar, J. Mandel, 2020, Journal of oncology.

Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study

J. Erinjeri, M. Wildgruber, J. Ricke, 2022, Cancers.

Phase 2 single arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi Sarcoma (cKS).

O. Merimsky, M. Lotem, E. Fenig, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Palbociclib in combination with sunitinib exerts a synergistic anti-cancer effect in patient-derived xenograft models of various human cancers types.

N. Moskovits, S. Stemmer, A. Bareket-Samish, 2022, Cancer letters.

Ofranogene obadenovec (VB-111), an anti-cancer gene therapy in combination with bevacizumab to improve overall survival compared to bevacizumab monotherapy in patients with rGBM: A phase 2 historically controlled trial.

P. Wen, L. Freedman, A. Brenner, 2016 .

Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling

R. Yerushalmi, H. Goldvaser, T. Shochat, 2018, Oncology.

Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study

P. Wen, T. Cloughesy, L. Freedman, 2019, Neuro-oncology.

Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases

D. Benchimol, B. Brenner, S. Morgenstern, 2021, Annals of Surgical Oncology.

79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

N. Girard, S. Siva, A. Allen, 2021 .

Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study

S. Paluch-Shimon, E. Gal-Yam, R. Yerushalmi, 2023, NPJ breast cancer.

Seeing the Trees From the Forest: Challenges in Subgroup Analysis-Based Guidelines in Oncology

R. Yerushalmi, D. Reinhorn, O. Rotem, 2024, Oncology reviews.